Access – Providing high quality trusted medicines regardless of geography or circumstance;
Leadership – Advancing sustainable operations and innovative solutions to improve patient health; and
Partnership – Leveraging our collective expertise to connect people to products and services.
Every day, we rise to the challenge to make a difference and here’s how the Counsel, GxP Compliance role will make an impact:
Key responsibilities for this role include:
Responsible for counseling clients on a wide range of issues with focus on GxP and Quality processes for the development, manufacture, and distribution of drugs, biologics, medical devices, supplements, and cosmetics.
Provide timely and effective counsel related to compliance with GxP regulations from various health authorities (e.g., FDA, EMA, TGA, Health Canada, WHO).
Assist with development of corrective action plans and responses following regulatory inspections and inquiries.
Assist in developing materials for regulatory meetings and preparing teams participating in such meetings.
Participate in committee meetings to review internal quality metrics and participate in site or project governance committees, as needed.
Provide guidance on product quality incidents and post-marketing reporting obligations and actions.
Work cross functionally with Quality, Regulatory, and other stakeholders to advise on and support process and systems improvements, including development of global quality policies and training materials.
Prepare and edit written reports and communications for internal and external use related to regulatory and GxP compliance requirements and obligations.
Monitor the external environment and advise teams on policy and regulatory developments related to GxP and related activities.
Manage engagements with outside counsel to ensure effective and efficient use.
Perform related duties as assigned.
The minimum qualifications for this role are:
Juris Doctorate is required and 7 years of experience in Pharmaceutical or biotechnology industry as inside or outside counsel. Three to five years of technical expertise in manufacturing and GxP auditing preferred. Related experience/education may also be considered.
Seven years of Legal experience advising clients directly or under the supervision of lawyers.
Licensed to practice law in one or more jurisdictions is required.
Exceptional oral and written communication skills, including strong presentation capabilities.
Strong interpersonal and conflict resolution skills.
Ability to work in a collaborative, team-oriented environment.
Background/education in science related discipline is preferred.
This role may have remote flexibility.
Proficiency in speaking, comprehending, reading and writing English is required.
Exact compensation may vary based on skills, experience, and location. The salary range for this position is $151,000 - $314,000.
At Viatris, we offer competitive salaries, benefits and an inclusive environment where you can use your experiences, perspectives and skills to help make an impact on the lives of others.
At Viatris, we offer competitive salaries, benefits and an inclusive environment where you can use your experiences, perspectives and skills to help make an impact on the lives of others.
Viatris is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, national origin, religion, age, color, sex, sexual orientation, gender identity, gender expression, disability, or protected veteran status, or any other characteristic protected by local, state, or federal laws, rules, or regulations.
#LI-Remote","datePosted":"2025-05-09T23:29","employmentType":"FULL_TIME","jobLocationType":"TELECOMMUTE","jobLocation":[{"@type":"Place","address":{"@type":"PostalAddress","streetAddress":"N/A","addressRegion":"N/A","addressLocality":"Remote in USA","postalCode":"N/A","addressCountry":"United States"}}],"directApply":false,"hiringOrganization":{"@type":"Organization","name":"Viatris","sameAs":"https://www.viatris.com/","logo":"https://storage.googleapis.com/simplify-imgs/companies/30432c31-feeb-422f-a8c3-bc7fc6da3a37/logo.jpg"},"baseSalary":{"@type":"MonetaryAmount","currency":"USD","value":{"@type":"QuantitativeValue","minValue":151000,"maxValue":314000,"unitText":"YEAR"}},"identifier":{"@type":"PropertyValue","name":"Viatris","value":"30432c31-feeb-422f-a8c3-bc7fc6da3a37"},"applicantLocationRequirements":{"@type":"Country","name":"United States"},"validThrough":"2025-06-08T23:29"}Full-Time
Global healthcare company providing medicines access
$151k - $314k/yr
Senior, Expert
Remote in USA
Candidates must be based in the United States.
Get referrals →
You have ways to get a Viatris referral from your network.
Applications through a referral are 3x more likely to get an interview!
Upload your resume to see how it matches 4 keywords from the job description.
PDF, DOC, DOCX, up to 4 MB
Viatris is a global healthcare company that combines generic and brand-name medicines to meet healthcare needs worldwide. The company provides access to high-quality medicines, having supplied them to around 1 billion patients in 2022. Viatris has a diverse portfolio of medicines and a global supply chain that ensures they reach people when and where they need them. This allows Viatris to address a wide range of health challenges, from acute conditions to chronic diseases, impacting all stages of life. Unlike many competitors, Viatris focuses on bridging the gap between generics and brands, aiming to empower individuals to live healthier lives. The company's goal is to enhance access to healthcare for people globally.
Company Size
10,001+
Company Stage
IPO
Headquarters
Canonsburg, Pennsylvania
Founded
1961
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Life Insurance
401(k) Retirement Plan
401(k) Company Match
Wellness Program
Paid Holidays
PITTSBURGH, May 7, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS) today announced that on May 5, 2025, its Board of Directors declared a quarterly dividend of $0.12 per share for each issued and outstanding share of the Company's common stock. The dividend is payable on June 16, 2025, to shareholders of record as of the close of business on May 23, 2025.About ViatrisViatris Inc. (Nasdaq: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris
PITTSBURGH, March 28, 2025 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) will report first quarter 2025 financial results on Thursday, May 8, 2025. Company executives will host a webcast at 8:30 a.m. ET on the same date to discuss the results.Investors and the general public are invited to listen to a live webcast of the call at investor.viatris.com or by calling 844.308.3344 or 412.317.1896 for international callers. A replay of the webcast also will be available on the website.About ViatrisViatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally
PITTSBURGH, March 5, 2025 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, will present at the Barclays 27th Annual Global Healthcare Conference in Miami Beach, FL on Tuesday, March 11, 2025. The company's fireside chat will begin at 2 p.m. ET.A live webcast of the event at can be found at investor.viatris.com. An archived version of the presentation will be available following the live event and can be accessed at the same location for a limited time.About ViatrisViatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally
PITTSBURGH, Feb. 27, 2025 /PRNewswire/ --
PITTSBURGH, Feb. 27, 2025 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced that on February 24, 2025, its Board of Directors approved a 2025 dividend policy of 48 cents ($0.48) per share and declared a quarterly dividend of 12 cents ($0.12) for each issued and outstanding share of the Company's common stock. The dividend is payable on March 18, 2025, to shareholders of record at the close of business on March 10, 2025. This marks the fifth consecutive year the Company has paid a dividend.About ViatrisViatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally